Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12613001042730Phase 4Completed
Phase 4, randomised, double-blind trial of plasma-lyte and saline, sponsored by Austin Hospital. Primary endpoint: Acute kidney injury or failure. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12613001042730.